The findings suggest a potentially elevated risk of vision impairment with semaglutide (Ozempic, Wegovy; Novo Nordisk) use compared to other weight loss and diabetes medications.

Multiple phase 3 clinical trials demonstrated dupilumab’s (Dupixent; Regeneron, Sanofi) effectiveness in reducing hives and itch in patients with chronic spontaneous urticaria compared with placebo.

Sequencing of antibody-drug conjugates (ADCs) in HER2-mutated breast cancer is crucial for optimizing treatment outcomes.

Authors of a review published in The Journal of Allergy and Clinical Immunology emphasized that blood eosinophil count and fractional exhaled nitric oxide cannot be relied on.

Lepodisiran, a small interfering RNA, demonstrated cholesterol-lowering effects at 16-mg, 96-mg, and 400-mg doses, with the highest dose being the most effective.

Antibody-drug conjugates have revolutionized metastatic breast cancer treatment and classification.

Hospital compounding is gaining renewed attention amid drug shortages, regulatory changes, and labor challenges, prompting pharmacies to leverage advanced technology for safer, more efficient, and compliant medication preparation.

The recommendations are not considered to be final until they are published in the Morbidity and Mortality Weekly Report.

Undetectable minimal residual disease rates improved with ongoing therapy.

The implementation of hospital-based discharge pharmacy services presents a savvy strategy to improve clinical outcomes for patients while simultaneously cutting excess spending.

Though the rate of coronary artery lesions decreased across both cohorts of this trial of children with Kawasaki disease, there were no differences in lesion reduction between those receiving intravenous immunoglobulin (IVIG) alone and those receiving IVIG with aspirin.

The data showed improvements in overall response rates, progression-free survival, and duration of response.

Medically integrated pharmacies improve collaboration, patient care, communication, and therapy management.

With a more direct mechanism of action against viral replication compared with standard treatments, the small interfering RNA (siRNA)-based MIR 19 treatment could revolutionize outpatient COVID-19 treatment.

At 28 to 179 days, COVID-19 infection in patients with preexisting chronic kidney disease (CKD) was associated with an increased risk of composite kidney events.

In mouse models, researchers identified that immune cells within the intestine may prevent unwarranted attacks against harmless food allergens.

Some patients with aplastic anemia treated with CK0801 achieved durable transfusion independence lasting over 3 years.

Pharmacy and physician were defendants.

Pharmacy technicians have a pivotal opportunity to advance professionally by proactively demonstrating leadership, offering solutions, and clearly communicating their value to health care leaders.

The safety profile of diazepam nasal spray among pediatric patients was consistent with older patients, supporting its use in this age group.

A palliative care pharmacist highlights a spectrum of clinical opportunities for patients, caregivers, and clinicians when rounding at the bedside.

The designation was supported based on data from the randomized, double-blind, active-controlled phase 3 interchangeability study.

Patients who received a pneumococcal conjugate vaccine 13 vaccination had slightly lower incidence of severe COVID-19 outcomes, but the directions of these associations were mixed.